JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2010, 59(3):103-111

Analytical methods for the determination of selected psychopharmaceuticals

R. Uřinovská1,*, M. Turjap2, H. Brozmanová1, M. Grundmann1,3
1 Fakultní nemocnice Ostrava, Ústav klinické farmakologie
2 Ostravská univerzita Ostrava, FZS, Ústav klinické farmakologie
2 Fakultní nemocnice Ostrava, Lékárna

At present at our disposal there are more than one hundred psychopharmaceuticals with more or less specific effects on the symptoms of individual mental disorders. Despite new therapeutic and diagnostic possibilities there are still many patients whose response to treatment with psychopharmaceuticals is not satisfactory. Introduction of a routine therapeutic monitoring of some psychopharmaceuticals could help to individualize and optimize the treatment according to the needs of a individual patient. This paper describes the analytical methods which enable their determination with regard to antidepressants and antipsychotics. At present the principal techniques for the determination of the levels of psychopharmaceuticals are gas and liquid chromatography. The principal biological material for the determination is serum or plasma. Samples for analysis are prepared most frequently by means of extraction from a liquid to a liquid or extraction on a solid phase. The published literature presents the methods making it possible to determine one or several psychopharmaceuticals simultaneously, including their possible active metabolites.

Keywords: psychopharmaceuticals; therapeutic drug monitoring; high-performance liquid chromatography; mass spectrometry

Received: April 27, 2010; Accepted: May 27, 2010; Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Uřinovská R, Turjap M, Brozmanová H, Grundmann M. Analytical methods for the determination of selected psychopharmaceuticals. Čes. slov. farm. 2010;59(3):103-111.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vanek, D., Raboch, J., Vanek, J.: The prevalence of depression in the Czech Republic. Eur. Psychiat., 2000; 15, 397S-98S. Go to original source...
    2. Suchopár, J. et al.: Remedia Compendium. 4. vyd. Praha: Panax, 2009; 242-262.
    3. Bouček, J., Pidrman, V.: Psychofarmaka v medicíně. 1. vyd. Praha: Grada Publishing, 2005; 16-40, 49-63, 114-162.
    4. Evans, W. E., Oellerich, M., Holt, D. W.: Therapeutic drug monitoring clinical guide. second edition. Cincinnati: Harvey Whitney Books Company, 1993; 2-10.
    5. Baumann, P., Hiemke, C., Ulrich, S., Eckermann, G., Gaertner, I., Gerlach, M., Kuss, H. J., Laux, G., Muller-Oerlinghausen, B., Rao, M. L., Riederer, P., Zernig, G.: The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiat., 2004; 37, 243-265. Go to original source... Go to PubMed...
    6. Shihabi, Z. K.: Sample matrix effects in capillary electrophoresis: II Acetonitrile deprotinization. J. Chromatogr. A, 1993; 652, 471-475. Go to original source...
    7. Martinavarro-Domínguez, A., Capella-Peiró, M. E., Gil-Agustí, M., Marcos-Tomás, J. V., Esteve-Romero, J.: Therapeutic drug monitoring of antikonvulsant drugs by micellas HPLC with direct injection of serum samples. Clin. Chem., 2002; 48, 1696-1702. Go to original source...
    8. Jasińska, A., Starczewska, B.: The use of the new SPE methods for isolation of some tricyclic antidepressant drugs from human serum. J. Pharm. Biomed. Anal., 2003; 31, 795-799. Go to original source... Go to PubMed...
    9. Štulík, K., Bosáková, Z., Coufal, P., Jelínek, I., Pacáková, V., Ševčík, J.: Analytické separační metody. 1. vyd. Praha: Karolinum 2004; 136-166, 210-220.
    10. Theurillat, R., Thormann, W.: Monitoring of tricyclic antidepressants in human serum and plasma by HPLC: characterization of a simple, laboratory developed method via external quality assessment. J. Pharm. Biomed. Anal., 1998; 18, 751-760. Go to original source... Go to PubMed...
    11. Schatz, D. S., Saria, A.: Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma by high-performence liquid chromatography with coulometric detection. Pharm., 2000; 60, 51-56. Go to original source... Go to PubMed...
    12. Martínez, M. A., Torre, C. S., Almarza, E.: A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. J. Anal. Toxicol., 2004; 28, 174-180. Go to original source... Go to PubMed...
    13. Silva, B. J. C., Lancas, F. M., Queiroz, M. E. C.: In tube solid-phase microextraction coupled to liquid chromatography (in tube-SPME/LC) analysis of nontricyclic antidepressants in human plasma. J. Chromatogr. B, 2008; 862, 181-188. Go to original source... Go to PubMed...
    14. Rasmussen, K. E., Pedersen-Bjergaard, S., Krogh, M., Ugland, H. G., Gronhaug, T.: Development of simple in-vial liquid-phase microextraction device for drug analysis compatible with capillary gas chromatography, capillary electrophoresis and high-performance liquid chromatography. J. Chromatogr. A, 2000; 873, 3-11. Go to original source... Go to PubMed...
    15. Castro, A., Concheiro, M., Quintela, O., Cruz, A., López-Rivadulla, M.: LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma Study of correlation between venlafaxine concentrations in both matrices. J. Pharm. Biomed. Anal., 2008; 48, 183-193. Go to original source... Go to PubMed...
    16. Kasper, S. C., Mattiuz, E. L., Swanson, S. P, Chiu, J. A., Johnson, J. T., Garner, C. O.: Determination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B, 1999; 726, 203-209. Go to original source... Go to PubMed...
    17. Maurer, H. H.: Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem, 2007; 388, 1315-1325. Go to original source... Go to PubMed...
    18. Dorey, R. C., Preskorn, S. H., Widener, P. K.: Results compared for tricyclic antidepressants as assayed by liquid chromatography and enzyme immunoassay. Clin. Chem., 1988; 34, 2348-2351. Go to original source...
    19. Saint-Marcoux, F., Sauvage, F. L., Marquet, P.: Current role of LC-MS in therapeutic drug monitoring. Anal. Bional. Chem., 2007; 388, 1327-1349. Go to original source... Go to PubMed...
    20. Chattergoon, D. S., Verjee, Z., Anderson, M., Johnson, D., McGuigan, M. A., Koren, G., Ito, S.: Carbamazepine interference with an immune assay for tricyclic antidepressants in plasma. Clin Toxicol, 1998; 36, 109-113. Go to original source... Go to PubMed...
    21. Dasgupta, A., Mc Neese, C., Wells, A.: Interference of carbamazepin and carbamazepine 10,11-epoxide in fluorescence polarization immunoassay for tricyclic antidepressants. Am. J. Clin. Pathol., 2004; 121, 418-425. Go to original source...
    22. Chromý, V., Fischer, J.: Analytické metody v klinické chemii. 1. vyd. Brno, Masarykova univerzita, 2000, s 96-97.
    23. Brunswick, D. J., Needelman, B., Mendels, J.: Specific radioimmunoassay of amitriptyline and nortriptyline. J. Clin. Pharmac., 1979; 7, 343-348. Go to original source... Go to PubMed...
    24. Dell'Aquila, C.: Separation of tricyclic antidepressants by capillary zone electrophoresis with N,N,N',N'-tetramethyl-1,3-butanediamine (TMBD) as an effective electrolyte additive. J. Pharm. Biomed. Anal., 2002; 30, 341-350. Go to original source... Go to PubMed...
    25. Pavlíková, L., Brozmanová, H., Kvasnička, F., Grundmann, M.: Terapeutické monitorování léků pomocí elektromigračních metod. Klin. Farmakol. Farm., 2007; 27, 45-49.
    26. Flores, J. R., Nevado, J. J. B., Salcedo, A. M. C., Díaz, M. P. C.: Development and validation method for determination of paroxetine and its metabolites by nonaqueous capillary electrophoresis in human urine. Experimental design for evaluating the ruggedness of the method. Electrophoresis, 2004; 25, 454-462. Go to original source... Go to PubMed...
    27. Tomita, M., Okuyama, T.: Application of capillary elecrophoresis to the simultaneous screening and quantitation of benzodiazepines. J. Chromatogr. Biomed Appl., 1996; 678, 331-337. Go to original source... Go to PubMed...
    28. Schafroth, M., Thormann, W., Allemann D.: Micellar electrokinetic capillary chromatography of benzodiazepines human urine. Electrophoresis, 1994; 15, 72-78. Go to original source... Go to PubMed...
    29. Tomita, M., Okuyama, T., Sato, S., Ishizu, H.: Simultaneous determination of nitrazepam and its metabolites in urine by micellar electrokinetic capillary chromatography. J. Chromatogr., 1993; 621, 249-255. Go to original source... Go to PubMed...
    30. Fernandes, Ch., Hoeck, E., Sandra, P., Lancas. F. M.: Determination of fluoxetine in plasma by gas chromatography-mass spectrometry using stir bar sorptive extraction. Anal. Chim. Acta, 2008; 614, 201-207. Go to original source... Go to PubMed...
    31. Torre, R., Ortuno, J., Pascual, J. A., González, S., Ballesta, J.: Quantitative determination of tricyclic antidepressants and their metabolites in plasma by solid-phase extraction (Bond-Elut TCA) and separation by capillary gas chromatography with nitrogen-phosphorous detection. Ther. Drug Monit., 1998; 20, 340-346. Go to original source... Go to PubMed...
    32. Linder, M. W., Keck, P. E.: Standards of laboratory practice: antidepressant drug monitoring. Clin. Chem., 1998; 44, 1074-1084.
    33. Vogeser, M., Seger, Ch.: A decade of HPLC-MS/MS in the routine clinical laboratory - Goals for further developments. Clin. Biochem., 2008; 41, 649-662. Go to original source... Go to PubMed...
    34. Langner, J., Gan, B. K, Liu, R. H., Baugh, L. D., Chand, P., Weng, J. L, Edwards, C., Walia, A. S.: Enzymatic digestion, solid-phase extraction, and gas chromatography/mass spectrometry of derivatized intact oxazepam in urine. Clin. Chem., 1991; 37, 1595-1601. Go to original source...
    35. Eap, C. B., Bouchoux, G., Amey, M., Cochard, N., Savary, L., Baumann, P.: Simultaneous determination of human plasma levels of citalopram, paroxeine, sertraline, and their metabolites by gas chromatography-mass spectrometry. J. Chromatogr. Sci., 1998; 36, 365-371. Go to original source... Go to PubMed...
    36. Mercolini, L., Bugamelli, F., Kenndler, E., Boncompagni, G., Franchini, L., Raggi, M. A.: Simultaneous determination of the antipsychotic drugs levomepromazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction. J. Chromatogr. B, 2007; 846, 273-280. Go to original source... Go to PubMed...
    37. Llorca, P. M., Coudore, F., Corpelet, Ch., Buyens, A., Hoareau, M., Eschalier, A.: Integration of olanzapine determination in HLPC-diode array detection system for routine psychotropic drug monitoring. Clin. Chem., 2001;47, 1719-1721. Go to original source...
    38. Akerman. K., Jolkkonen, J., Parviainen, M., Penttila, I.: Analysis of low-dose benzodiazepines by HPLC with automated solid phase extraction. Clin. Chem., 1996; 42, 1412-1416. Go to original source...
    39. Malfará, W. R., Bertucci, C., Queiroz M. E. C., Carvalho, S. A. D., Bianchi, M. L. P., Cesarino, E. J., Crippa, J. A., Queiroz, R. H. C.: Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants. J. Pharm. Biomed. Anal., 2007; 44, 955-962. Go to original source... Go to PubMed...
    40. Carrillo, J. A., Ramos, S. I., Agundez, J. A. G., Martinez, C, Benitez, J.: Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: Probe of CYP3A. Ther. Drug Monit., 1998; 20, 319-324. Go to original source... Go to PubMed...
    41. Kristoffersen, L., Bugge, A., Lundanes, E., Slordal, L.: Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection. J. Chromatogr. B, 1999; 734, 229-246. Go to original source... Go to PubMed...
    42. Mandrioli, R., Mercolini, L., Cesta, R., Fanali, S., Amore, M., Raggi, M. A.: Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection. J. Chromatogr. B, 2007; 856, 88-94. Go to original source... Go to PubMed...
    43. Suckow, R. F., Zhang M. F., Cooper, T. B.: Sensitive and selective liquid-chromatographic assay for fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. Clin. Chem., 1992; 38/9, 1756-1761. Go to original source...
    44. Kirchherr, H., Kühn-Velten, W. N.: Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: A multi-level, single-sample approach. J. Chromatogr. B, 2006; 843, 100-113. Go to original source... Go to PubMed...
    45. Sabbioni, C., Bugamelli, F., Varani, G., Mercolini, L., Musenga, A., Saracino, M. A., Fanali, S., Raggi, M. A.: A rapid HPLC-DAD method for the analysis of fluoxetine and norfluoxetine in plasma from overdose patients. J. Pharm. Biomed. Anal., 2004; 36, 351-356. Go to original source... Go to PubMed...
    46. Titier, K., Déridet, E., Cardone, E., Abouelfath, A., Moore, N.: Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose. J. Chromatogr. B, 2002; 772, 373-378. Go to original source... Go to PubMed...
    47. Ertürk, S., Cetin, S. M., Atmaca, S., Ersoy, L., Baktir, G.: A Senzitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma with fluorescence detection. Ther. Drug Monit., 2005; 27, 38-43. Go to original source... Go to PubMed...
    48. Mandrioli, R., Saracino, M. A., Ferrari, S., Berardi, D., Kenndler, E., Raggi, M. A: HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma. J. Chromatogr. B, 2006; 836, 116-119. Go to original source... Go to PubMed...
    49. Juan, H., Zhiling, Z., Huande, L.: Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B, 2005; 820, 33-39. Go to original source... Go to PubMed...
    50. Pistos, C., Panderi, I., Atta-Poltou, J.: Liquid chromatrography-positive ion electrospray mass spectrometry method for the quatification of citalopram in human plasma. J. Chromatogr. B, 2004; 810, 235-244. Go to original source... Go to PubMed...
    51. Bhatt, J., Jangid, A., Venkatesh, G., Subbaiah, G., Singh, S.: Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma. J. Chromatogr. B, 2005; 829, 75-81. Go to original source... Go to PubMed...
    52. Al-Dirbashi, O. Y., Aboul-Enein, H. Y., Al-Odaib, A., Jacob, M., Rashed, M. S.: Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma. Biomed. Chromatogr., 2006; 20, 365-368. Go to original source... Go to PubMed...
    53. Niederländer, H. A., Koster, E. H., Hilhorst, M. J., Metting, H. J., Eilders, M., Ooms, B., de Jong, G. J.: High throughput terapeutic drug monitoring of clozapine and metabolites in serum by on-line coupling of solid phase extraction with liquid chromatgraphy-mass spectrometry. J. Chromatogr. B, 2006; 834, 98-107. Go to original source... Go to PubMed...
    54. Peak, I. B., Moon, Y., Ji, H. Y, Hui-Hyun, K., Hye, W. L., Yong-Bok, L., Hye, S. L.: Hydrophilic interaction liquid chromatography-tandem mass spectrometry for determination of levosulpirid in human plasma. J. Chromatogr. B, 2004; 809, 345-350. Go to original source...
    55. Kubo, M., Mizooku, Y., Hirao, Y., Osumi, T.: Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma. J. Chromatogr. B, 2005; 822, 294-299. Go to original source... Go to PubMed...
    56. Singh, S. S., Shah, H., Gupta, S., Jain, M., Sharma, K., Thakkar, P., Shah, R.: Liquid chromatography-electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study. J. Chromatogr. B, 2004; 811, 209-215. Go to original source...
    57. Gschwend, M. H., Arnold, P., Ring, J., Martin, W.: Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. J. Chromatogr. B, 2006; 831, 132-139. Go to original source... Go to PubMed...
    58. Djordjevic, S., Kovacevic, I., Miljkovič, B., Vuksanovic, J., Pokrajac, M.: Liquid chromatographic-mass spectrometric method for the determination of flouxetine and norfluoxetine in human plasma: application to clinical study. Il. Farmaco, 2005; 60, 345-349. Go to original source... Go to PubMed...
    59. Chauhan, B., Rani, S., Guttikar, S., Zope, A., Jadon, N., Padh, H.: Analytical method development and validation of miaserin hydrochloride and its metabolite in human plasma by LC-MS. J. Chromatogr. B, 2005; 823, 69-74. Go to original source... Go to PubMed...
    60. Pistos, C., Koutsopoulou, M., Panderi I.: A validated liquid chromatographic tandem mass spectrometric method for the determination of mirtazapine and demethylmirtazapine in human plasma: application to a pharmacokinetic study. Anal. Chim. Acta, 2004; 514, 15-26. Go to original source...
    61. Chen, X., Duan, X., Dai, X., Zhong, D.: Development and validation of liquid chromatographic/tandem mass spectrometric method for the determination of sertraline in human plasma. Rapid Commun. in Mass Spectrom., 2006; 20, 2483-2489. Go to original source... Go to PubMed...
    62. Jain, D. S., Sanyal, M., Subbaiah, G., Pande, U. C., Shrivastav, P.: Rapid and sensitive method for the determination of sertraline in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). J. Chromatogr. B, 2005; 829, 69-74. Go to original source... Go to PubMed...
    63. Hempenius, J., Steenvoorden, R. J. J. M, Lagerwerf, F. M., Wieling, J. J., Jonkman, H. G.: "High throughput" solid-phase extraction technology and turbo ionspray LC-MS-MS applied to the determination of haloperidol in human plasma. J. Pharm. Biomed. Anal., 1999; 20, 889-898. Go to original source... Go to PubMed...
    64. Berna, M., Shugert, R., Mullen, J.: Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry. J. Mass Spectrom., 1998; 33, 1003-1008. Go to original source...
    65. Berna, M., Ackermann, B., Ruterbories, K., Glass, S.: Determination of olanzapin in human blood by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B, 2002; 767, 163-168. Go to original source... Go to PubMed...
    66. Bogusz, M. J., Krüger, K. D., Maier, R. D., Erkwoh, R., Tuchtenhagen, F.: Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B, 1999; 732, 257-369. Go to original source... Go to PubMed...
    67. Aravagiri, M., Marder, S., R.: Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electorospray tandem mass spectrometry. J. Mass Spectrom., 2000; 35, 718-724. Go to original source...
    68. Bhatt, J., Subbaiah, G., Singh, S.: Liquid chromatography/tandem mass spectrometry method for simultaneous determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma. Rapid Commun. Mass Spectrom., 2006; 20, 2019-2114. Go to original source... Go to PubMed...
    69. Remmerie, B. M. M., Sips, L. L. A., Vries, R., Jong, J., Schothuis, A. M., Hooijschuur, E. W. J., Merbel, N. C.: Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B, 2003; 783, 461-472. Go to original source... Go to PubMed...
    70. Zhou, Z., Li, X., Li, K., Xie, Z., Cheng, Z., Peng, W., Wang, F., Zhu, R., Li, H.: Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B, 2004; 802, 257-262. Go to original source... Go to PubMed...
    71. Massaroti, P., Cassioano, N. M., Duarte, L. F., Campos, D. R., Marchioretto, M. A. M., Bernasconi, G., Calafatti, S., Barros, F. A. P., Meurer, E. C., Pedrazzoli, J.: Validation of a selective method for determination of paroxetine i human plasma by LC-MS/MS. J. Pharm Pharmaceut. Sci., 2005; 8, 340-347.
    72. Sutherland, F. C. W., Badenhorst, D., de Jager, A. D., Scanes, T., Hundt, H. K. L., Swart, K. J., Hundt, A. F.: Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma. J. Chromatogr A, 2001; 914, 45-51. Go to original source... Go to PubMed...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.